Holdings of ProShares Ultra Nasdaq Biotechnology
ProShares Trust ·260 declared positions · as of Feb 28, 2026
Original filing · Net assets 91.7M $ · Ten largest lines: 46.7 % of the equity sleeve
Sector breakdown
- Health care 49.1 %
- Materials 2.8 %
- Industrials 1.0 %
- Unattributed 47.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 89.4 %
- NL 2.2 %
- BM 1.5 %
- FR 1.5 %
- IE 1.3 %
- DK 1.2 %
- DE 0.8 %
- CA 0.6 %
- CH 0.4 %
- KY 0.3 %
- SG 0.2 %
- JE 0.1 %
- Other countries 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 224 | 55.3M $ | 89.45 % |
| 2 | NL | 4 | 1.3M $ | 2.17 % |
| 3 | BM | 1 | 929.4K $ | 1.50 % |
| 4 | FR | 2 | 925.2K $ | 1.50 % |
| 5 | IE | 4 | 826.8K $ | 1.34 % |
| 6 | DK | 2 | 741.4K $ | 1.20 % |
| 7 | DE | 1 | 514.7K $ | 0.83 % |
| 8 | CA | 4 | 369.8K $ | 0.60 % |
| 9 | CH | 2 | 278.2K $ | 0.45 % |
| 10 | KY | 5 | 160K $ | 0.26 % |
| 11 | SG | 1 | 107.6K $ | 0.17 % |
| 12 | JE | 1 | 70.7K $ | 0.11 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Pharvaris NV | 2,958 | 84K $ | 0.09 % |
| 102 | Vericel Corp | 2,335 | 83.3K $ | 0.09 % |
| 103 | Relay Therapeutics Inc | 8,003 | 82.1K $ | 0.09 % |
| 104 | Tyra Biosciences Inc | 2,464 | 82.1K $ | 0.09 % |
| 105 | Enliven Therapeutics Inc | 2,741 | 81.4K $ | 0.09 % |
| 106 | Agios Pharmaceuticals Inc | 2,692 | 81.4K $ | 0.09 % |
| 107 | Sarepta Therapeutics Inc | 4,838 | 81.1K $ | 0.09 % |
| 108 | Zymeworks Inc | 3,456 | 80.5K $ | 0.09 % |
| 109 | Genmab A/S | 2,699 | 79.5K $ | 0.09 % |
| 110 | Definium Therapeutics Inc | 4,548 | 79.4K $ | 0.09 % |
| 111 | Innoviva Inc | 3,453 | 79.3K $ | 0.09 % |
| 112 | Oruka Therapeutics Inc | 2,236 | 76.9K $ | 0.08 % |
| 113 | Amylyx Pharmaceuticals Inc | 5,071 | 76.9K $ | 0.08 % |
| 114 | ANI Pharmaceuticals Inc | 1,037 | 76.6K $ | 0.08 % |
| 115 | Novavax Inc | 7,504 | 76.1K $ | 0.08 % |
| 116 | Harmony Biosciences Holdings Inc | 2,660 | 75.9K $ | 0.08 % |
| 117 | Sionna Therapeutics Inc | 2,061 | 75.3K $ | 0.08 % |
| 118 | Nurix Therapeutics Inc | 4,680 | 74.7K $ | 0.08 % |
| 119 | RAPT THERAPEUTICS INC | 1,279 | 74.2K $ | 0.08 % |
| 120 | LEGEND BIOTECH CORP | 3,888 | 73.9K $ | 0.08 % |
| 121 | Intellia Therapeutics Inc | 5,348 | 73.7K $ | 0.08 % |
| 122 | Ardelyx Inc | 11,220 | 73.5K $ | 0.08 % |
| 123 | Iovance Biotherapeutics Inc | 18,330 | 70.8K $ | 0.08 % |
| 124 | Novocure Ltd | 5,171 | 70.7K $ | 0.08 % |
| 125 | Trevi Therapeutics Inc | 5,921 | 70.6K $ | 0.08 % |
| 126 | AnaptysBio Inc | 1,278 | 70.4K $ | 0.08 % |
| 127 | Tango Therapeutics Inc | 6,219 | 69.3K $ | 0.08 % |
| 128 | MBX Biosciences Inc | 2,073 | 67.5K $ | 0.07 % |
| 129 | EyePoint Inc | 3,822 | 67.1K $ | 0.07 % |
| 130 | Kodiak Sciences Inc | 2,450 | 65.7K $ | 0.07 % |
| 131 | ZENAS BIOPHARMA INC | 2,478 | 65.3K $ | 0.07 % |
| 132 | Immunocore Holdings PLC | 2,015 | 65.1K $ | 0.07 % |
| 133 | Rapport Therapeutics Inc | 2,201 | 63.9K $ | 0.07 % |
| 134 | Corvus Pharmaceuticals Inc | 3,449 | 63K $ | 0.07 % |
| 135 | Precigen Inc | 16,338 | 61.9K $ | 0.07 % |
| 136 | AtaiBeckley Inc | 16,770 | 60.9K $ | 0.07 % |
| 137 | Collegium Pharmaceutical Inc | 1,460 | 60.8K $ | 0.07 % |
| 138 | ORIC Pharmaceuticals Inc | 4,497 | 60.5K $ | 0.07 % |
| 139 | Septerna Inc | 2,067 | 60K $ | 0.07 % |
| 140 | Vir Biotechnology Inc | 6,424 | 58.4K $ | 0.06 % |
| 141 | Alvotech SA | 14,454 | 57.7K $ | 0.06 % |
| 142 | Taysha Gene Therapies Inc | 12,648 | 57.3K $ | 0.06 % |
| 143 | Savara Inc | 9,395 | 56.6K $ | 0.06 % |
| 144 | Monte Rosa Therapeutics Inc | 3,007 | 53.4K $ | 0.06 % |
| 145 | Sana Biotechnology Inc | 12,300 | 51.8K $ | 0.06 % |
| 146 | Phibro Animal Health Corp | 946 | 51.6K $ | 0.06 % |
| 147 | Grifols SA | 5,633 | 51.3K $ | 0.06 % |
| 148 | Day One Biopharmaceuticals Inc | 4,741 | 50.3K $ | 0.05 % |
| 149 | AbCellera Biologics Inc | 13,822 | 49.9K $ | 0.05 % |
| 150 | Inhibrx Biosciences Inc | 672 | 49.8K $ | 0.05 % |
| 151 | Geron Corp | 29,476 | 49.5K $ | 0.05 % |
| 152 | UroGen Pharma Ltd | 2,162 | 46.9K $ | 0.05 % |
| 153 | Xeris Biopharma Holdings Inc | 7,662 | 46.9K $ | 0.05 % |
| 154 | MannKind Corp | 14,180 | 46.5K $ | 0.05 % |
| 155 | Ventyx Biosciences Inc | 3,295 | 46K $ | 0.05 % |
| 156 | Fortrea Holdings Inc | 4,266 | 45.7K $ | 0.05 % |
| 157 | uniQure NV | 2,877 | 45K $ | 0.05 % |
| 158 | ArriVent Biopharma Inc | 1,906 | 43.8K $ | 0.05 % |
| 159 | Pacira BioSciences Inc | 1,986 | 43.5K $ | 0.05 % |
| 160 | Amphastar Pharmaceuticals Inc | 2,122 | 42.9K $ | 0.05 % |
| 161 | Theravance Biopharma Inc | 2,340 | 42.7K $ | 0.05 % |
| 162 | GH RESEARCH PLC | 2,864 | 42.5K $ | 0.05 % |
| 163 | Bicara Therapeutics Inc | 2,530 | 42.5K $ | 0.05 % |
| 164 | ARS Pharmaceuticals Inc | 4,564 | 42.4K $ | 0.05 % |
| 165 | Cullinan Therapeutics Inc | 2,728 | 42.3K $ | 0.05 % |
| 166 | Xencor Inc | 3,298 | 42.1K $ | 0.05 % |
| 167 | CytomX Therapeutics Inc | 7,823 | 42K $ | 0.05 % |
| 168 | Arbutus Biopharma Corp | 8,881 | 41.4K $ | 0.05 % |
| 169 | Phathom Pharmaceuticals Inc | 3,285 | 41.3K $ | 0.05 % |
| 170 | Castle Biosciences Inc | 1,348 | 39.9K $ | 0.04 % |
| 171 | Omeros Corp | 3,274 | 39.5K $ | 0.04 % |
| 172 | Arvinas Inc | 2,965 | 39.3K $ | 0.04 % |
| 173 | Prime Medicine Inc | 8,335 | 38.5K $ | 0.04 % |
| 174 | KalVista Pharmaceuticals Inc | 2,334 | 38K $ | 0.04 % |
| 175 | Janux Therapeutics Inc | 2,777 | 37.8K $ | 0.04 % |
| 176 | Annexon Inc | 6,683 | 37.4K $ | 0.04 % |
| 177 | Personalis Inc | 4,101 | 37.2K $ | 0.04 % |
| 178 | Esperion Therapeutics Inc | 11,038 | 37K $ | 0.04 % |
| 179 | BioAge Labs Inc | 1,656 | 36.9K $ | 0.04 % |
| 180 | Mesoblast Ltd. | 2,264 | 35.9K $ | 0.04 % |
| 181 | Kura Oncology Inc | 4,018 | 35.1K $ | 0.04 % |
| 182 | ZAI LAB LTD | 1,808 | 34.7K $ | 0.04 % |
| 183 | Compass Pathways plc | 4,351 | 30K $ | 0.03 % |
| 184 | Rigel Pharmaceuticals Inc | 838 | 29.1K $ | 0.03 % |
| 185 | Allogene Therapeutics Inc | 10,377 | 28.8K $ | 0.03 % |
| 186 | MeiraGTx Holdings plc | 3,717 | 28.1K $ | 0.03 % |
| 187 | Replimune Group Inc | 3,622 | 27.7K $ | 0.03 % |
| 188 | Design Therapeutics Inc | 2,630 | 27.5K $ | 0.03 % |
| 189 | Neumora Therapeutics Inc | 7,715 | 26.9K $ | 0.03 % |
| 190 | CorMedix Inc | 3,638 | 25.9K $ | 0.03 % |
| 191 | Ironwood Pharmaceuticals Inc | 7,512 | 25.7K $ | 0.03 % |
| 192 | 4D Molecular Therapeutics Inc | 2,638 | 25.5K $ | 0.03 % |
| 193 | Rocket Pharmaceuticals Inc | 4,990 | 25K $ | 0.03 % |
| 194 | Vanda Pharmaceuticals Inc | 2,729 | 24.3K $ | 0.03 % |
| 195 | Lexeo Therapeutics Inc | 3,370 | 24.2K $ | 0.03 % |
| 196 | Maravai LifeSciences Holdings Inc | 6,696 | 23.8K $ | 0.03 % |
| 197 | Lyell Immunopharma Inc | 979 | 23.5K $ | 0.03 % |
| 198 | Pacific Biosciences of California Inc | 13,941 | 23.4K $ | 0.03 % |
| 199 | Zevra Therapeutics Inc | 2,600 | 23.2K $ | 0.03 % |
| 200 | Kamada Ltd | 2,664 | 23.2K $ | 0.03 % |